Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program

2024-12-18 Complete Genomics HaiPress

FRAMINGHAM,Mass.,Dec. 17,2024 -- Complete Genomics,a San Jose,California based genomics tools manufacturer,today announced Framingham,Massachusetts based Eurofins Clinical Enterprise,LLC as the newest addition to its Sequencing Service Provider Program.

Complete Genomics' Service Provider Programconnects its customers to a network of service providers,offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms.

As part of the partnership,Eurofins Clinical Enterprise will use the DNBSEQ-T7RS™* ("T7"),Complete Genomics' flagship sequencer,to perform whole genome sequencing,low-pass whole genome sequencing (lpWGS),spatial-resolved transcriptomics,and single-cell sequencing.

The Eurofins Clinical Enterprise team expressed their enthusiasm about utilizing the T7 to enhance the company's flexibility in handling a wide range of research project sizes,while maintaining competitive pricing and quick turnaround times.

"This partnership is another way that Complete Genomics and its partners are expanding what is possible while also lowering costs and turnaround time for our customers," said Rob Tarbox,VP of Product and Marketing at Complete Genomics.

About Complete Genomics

Complete Genomics is a pioneering life sciences company that provides novel,end to end DNA sequencing solutions. It has been at the forefront of high throughput cost-effective sequencing technology development since its inception in 2005. Our products have powered over 9,400 publications across a wide array of applications. To learn more,visit www.completegenomics.com.

* For Research Use Only. Not for use in diagnostic procedures.

About Eurofins Clinical Enterprise,LLC

Eurofins Clinical Enterprise is engineered for integration and powered for collaboration. As an advanced,CLIA-certified,CAP-accredited,NY CLEP-licensed multiomic services laboratory,we provide customizable data integrations and fast,accurate testing at competitive prices. Clinical Enterprise strives to build bridges to discovery in academic research,biopharma uses,clinical studies,lifestyle genomics,and more.

Eurofins Scientific through its subsidiaries is a world leader in food,environment,pharmaceutical and cosmetic product testing,discovery pharmacology,forensics,advanced material sciences,and agroscience contract research services. To learn more,visit www.clinicalenterprise.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map